立方制药 (003020.SZ)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

财务摘要(单季度)(立方制药)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年第三季度2024年第二季度2024年第一季度2023年第四季度2023年第三季度2023年第二季度2023年第一季度
单季度财务指标:
 单季度每股收益(元) ------1.00
 单季度销售毛利率(%) 66.0073.0069.0072.0064.0055.0037.00
 单季度销售净利率(%) 11.0011.008.0016.0016.0014.008.00
 单季度净资产收益率ROE(%) 2.003.002.003.003.004.004.00
 单季度总资产净利率ROA(%) 2.002.001.003.002.003.003.00
单季度财务摘要:
 单季度营业总收入(元) 355,783,286.00435,713,860.00333,618,254.00376,287,529.00256,710,773.00455,974,062.00811,816,818.00
 单季度营业总成本(元) 318,638,514.00374,557,519.00307,762,871.00324,988,376.00222,627,799.00404,618,116.00730,374,002.00
 单季度营业收入(元) 355,783,286.00435,713,860.00333,618,254.00376,287,529.00256,710,773.00455,974,062.00811,816,818.00
 单季度营业利润(元) 44,368,122.0058,180,458.0029,015,119.0063,938,837.0044,311,184.0069,095,942.0077,924,247.00
 单季度利润总额(元) 44,376,948.0057,934,864.0029,008,343.0066,509,337.0044,258,141.0068,614,807.0078,034,457.00
 单季度净利润(元) 39,663,926.0048,537,086.0027,455,521.0061,051,895.0041,701,435.0064,987,570.0066,141,680.00
 单季度归属母公司股东的净利润(元) 41,548,837.0047,058,695.0030,372,220.0055,297,502.0040,245,968.0064,987,570.0066,141,680.00
 单季度经营活动产生的现金流量(元) 48,957,471.0062,236,417.0015,482,874.00141,691,760.002,328,853.0038,053,465.0021,600,909.00
 单季度投资活动产生的现金流量(元) -23,527,576.00116,976,763.00-328,421,287.00166,246,044.00-37,970,308.00-42,063,289.00-401,062,190.00
 单季度筹资活动产生的现金流量(元) 26,662,206.00-98,862,084.00-2,435,065.00-7,921,748.001,811,332.003,459,592.0039,276,136.00
 单季度现金及现金等价物净增加(元) 52,081,875.0080,350,868.00-315,371,864.00300,014,110.00-33,830,752.00-500,376.00-340,189,084.00

前瞻产业研究院